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Aims Several studies reported on the moderate diagnostic yield of elective invasive coronary angiography (ICA) regarding
the presence of coronary artery disease (CAD), but limited data are available on how prior testing for ischaemia may
contribute to improve the diagnostic yield in an every-day clinical setting. This study aimed to assess the value and
use of cardiac myocardial perfusion single photon emission computed tomography (MPS) in patient selection prior to
elective ICA.
Methods
and results
The rate of MPSwithin 90 days prior to elective ICAwas assessed and the non-invasive test results were correlatedwith
thepresenceofobstructiveCADon ICA(defined as stenosis of≥50%of amajorepicardial coronary vessel).Multivariate
logistic regression analysiswas performed to identify predictors of obstructiveCAD.A total of 7530 consecutivepatients
were included.At catheterization, 3819 (50.7%)werediagnosedashavingobstructiveCAD.Patientswith apositive result
onMPS (performed in 23.5% of patients) were significantly more likely to have obstructiveCADas assessed by ICA than
thosewhodid not undergonon-invasive testing (74.4 vs. 45.6%, P, 0.001). Furthermore, a pathologicalMPS resultwas a
strong, independent predictor for CAD findings among traditional risk factors and symptoms.
Conclusion In an every-day clinical setting, the use of MPS substantially increases the diagnostic yield of elective ICA and provides
incremental value over clinical risk factors and symptoms in predicting obstructiveCAD, thus emphasizing its importance
in the decision-making process leading to the use of diagnostic catheterization.
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Introduction
Current guidelines recommend comprehensive risk stratification for
patients undergoing assessment for coronary artery disease (CAD).
Direct referral for invasive coronary angiography (ICA) is recom-
mended only for patients with high pre-test probability of CAD,
whereas patients at intermediate risk are to undergo non-invasive
ischemia testing.1 The importance of adherence to these guidelines
is underscored by studies demonstrating that stress testing prior to
ICA and percutaneous coronary intervention (PCI) has been asso-
ciated with lower overall diagnostic costs, shorter hospital stays, and
lower rates of revascularization, without adverse effects on cardiac
death or myocardial infarction.2,3 The fact that the application of
risk scores leads to a substantial fraction of patients being accredited
to a low-to-moderate risk further corroborates the importance
of non-invasive stress testing prior to elective ICA. In reality,
however, only a minority of patients undergoing ICA are referred
to a stress test prior to the procedure.4 Hence, the lack of non-
invasive testing of patients at low-to-moderate risk for CAD may
contribute to the reported low diagnostic yield of ICA.5
Conversely, against this background, it may be hypothesized that
the application of non-invasive stress testing according to guidelines
may potentially contribute to improving the diagnostic yield of ICA
while simultaneously reducing the rate of normal and thus unneces-
sary invasive procedures. However, while numerous studies have
reported on the diagnostic performance of individual non-invasive
stress tests suchasmyocardial perfusionsinglephotonemissioncom-
puted tomography (MPS),6 it remains to be elucidated how MPS
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performs in a real-world clinical setting with regard to its ability to
correctly triage patients prior to elective ICA.
Thus, this retrospective study aimed to assess the role and value of
cardiac imaging (MPS)prior toelective ICAwith regard to its ability to
improve the diagnostic yield of ICA and thus to improve insight into
indication quality at our institution.
Methods
Patient population and data sources
Weretrospectively identified patientswithout known priorCADunder-
going elective ICA over the course of 10 years (between 1 April 2000
and 31 March 2010) from the database of the patient information
system of the Cardiology Department of the University Hospital Basel,
Switzerland. Patients with an indication for emergency or urgent ICA
were excluded, as were patients who did undergo ICA as part of pre-
operative assessment and those with a history of valvular surgery or
cardiac transplantation. Information on demographic characteristics,
symptoms (i.e. typical and atypical chest pain, dyspnoea, or a general
intolerance to physical effort) and clinical risk factors were recorded
for each patient, as well as the results of MPS prior to ICA. A modified
Framingham Risk Score was calculated based on the available clinical
data as previously described:5 A score of one point was assigned for
the presence of documented dyslipidaemia or the use of statins and for
a history of hypertension or the use of any antihypertensive medication
if no values for blood lipids or blood pressure were available.
Cardiac imaging
The MPS results performed within 90 days prior to ICAwere recorded
for each patient.
MPS was performed using a 1-day gated single isotope 99mTc-Sestamibi
stress/rest protocol or a 1-day gated dual-isotope 201Tl-rest/99mTc-
Sestamibi stress protocol as suggested by the guidelines of the European
Association of Nuclear Medicine7 and as previously reported.8,9 When-
ever possible, ergometry using standard protocols was performed for
stress imaging. If physical exercise was not possible or insufficient, a
pharmacological stimulation (usingadenosinewithadoseof140 mg/kg per
min for 6 min) was used either combined with physical stress or alone.
99mTc-sestamibi was injected after 3 min of adenosine infusion. Images
were scored by an experienced nuclear cardiologist using a 20-segment
model with a 5-point scale (ranging from 0 ¼ normal to 4 ¼ no uptake).
A summed stress score (SSS) was obtained by adding the scores of the
20 segments of the stress images, and a summed rest score (SRS) by
adding the scores of the 20 segments on the rest images.7 To assess
defect reversibility, a summed difference score (SDS) was calculated by
subtracting SRS from SSS, reflecting the severity and extent of ischaemia.
An SSS ≥4 and/or an SDS ≥2 was considered pathological.8 Of note,
MPS interpretationwasconsistentlyperformedandrecordedprior to ICA.
Obstructive coronary artery disease
ICA was performed according to the modified Judkin’s technique.10
Obstructive CAD was defined as the angiographic presence of at least
one stenosis of 50% or more in any major epicardial vessel or branch
vessel. The degree of stenosis was estimated from a comparison with
the diameter of the normal reference vessel proximal to the lesion and
defined by the invasive cardiologist conducting ICA.
Statistical analysis
Continuous variables are presented as medians and interquartile ranges,
and categorical variables as percentages. Wilcoxon–Mann–Whitney or
Student’s t-test was used to compare continuous variables, while a x2
test was used to compare categorical variables. Multivariate logistic-
regression analysis was performed to identify factors predicting obstruct-
ive CAD with the following variables included into analysis: traditional
cardiovascular risk factors, Framingham Risk Score, cardiac symptoms
(i.e. dyspnoea, atypical and typical angina), and a positive MPS. Further-
more, four separate models were built to assess the relative value of
these factors in predicting obstructive CAD; we started with a model for
predicting risk for obstructive CAD as assessed with the use of the Fra-
mingham Risk Score alone, then added into the model clinical risk
factors, followed by documented symptoms, andfinally the results of non-
invasive stress testing.Thepredictivevalueofeachmodelenteredstepwise
into the Cox proportional hazard model is represented by the respective
global x2 value. Significance levels for increments in the global x2 values
were calculated. P-values of , 0.05 were considered statistically signifi-
cant for all tests. SPSS 18 (SPSS Inc.) was used for statistical testing.
Results
Study population
A total of 13 143 consecutive patients that underwent elective ICA
were screened. Of these, 5613 (42.7%) patients were excluded
because they met one or more exclusion criteria: 3413 (26.0%)
had a known history of myocardial infarction, 694 (5.3%) had under-
gone cardiac surgery, 1758 (13.4%) underwent ICA as part of
preoperative assessment, and 1304 (9.9%) had a history of prior per-
cutaneous coronary intervention. Thus, a total of 7530 (57.3%)
patients were included into the final analysis for the present study.
Patient baseline characteristics for the overall population and strati-
fied by whether or not MPS was performed prior to ICA are given
inTable1 and2, respectively.Of note, patients inwhomMPSwasper-
formed differed significantly from those without prior MPS with
regard to all clinical characteristics except age, current smoking
status, and the ratio of patients with a high Framingham risk score.
Angiographic findings and cardiac imaging
ICA revealed obstructive CAD in 3819 (50.7%) patients, of whom
528 (11.9%) had multi-vessel disease. MPS was performed within
90 days prior to ICA in a total of 1773 (23.5%) patients (18.9%
among low-risk patients, 25.5% among moderate-risk patients, and
28.5% among patients presenting with a high risk for CAD according
to the modified Framingham Risk Score).
Patients with a positiveMPS result had a significantly higher rate of
obstructive CAD than those who did not undergo MPS (74.4 vs.
45.6%, P, 0.001). Figure 1 shows that this finding holds true for all
Framingham Risk Score categories with constant differences in
rates of obstructive CADfindings for low risk, for those atmoderate
risk, and for patients at high risk for obstructive CAD.
Figure 2 demonstrates the results of four separate models for the
prediction of a finding of obstructive CAD by ICA represented by
the globalx2 value foreachmodel:Model (1) includingonly themodi-
fied Framingham Risk Score (global x2 331.7, P, 0.001); Model (2)
including clinical risk factors (global x2 643.7, P, 0.001); Model (3)
adding clinical symptoms (global x2 1043.0, P, 0.001); Model (4) in-
clusion of the results of MPS (global x2 1225.2, P, 0.001).
Expectedly, as shown in Figure 3, in a population at low risk for
CAD, the addition of MPS provided only very limited additional
value over clinical symptoms. By contrast, in patients at moderate
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and high risk, MPS substantially increased the model’s predictive
ability as shown in Figure 3.
Predictors of obstructive coronary artery
disease
Independent predictors of obstructive CAD were male gender,
typical angina pectoris, a positive MPS, diabetes, smoking, having a
positive family history, and increasing age (Table 3).
Discussion
Our study demonstrates that MPS independently predicts obstruct-
ive CAD findings by ICA in an unselected population without known
CAD irrespective of traditional risk factors and symptoms. Substan-
tial increase in obstructive CAD findings at catheterization was
observed if ICAwas performed after objective evidence of ischaemia
by MPS (74.4 vs. 45.6%, P, 0.0001). In our study cohort, the overall
diagnostic yield of invasive cardiac catheterization was lowwith only
about half of patients (50.7%) having obstructive CAD.
Thesefinding areessentially in linewithprevious results addressing
the rate ofCADfindings at ICA.11 A recently published large study by
Patel et al.5 reported that only a minority (38%) of the 400 000
patients who underwent elective ICA at 663 hospitals in the USA
had obstructive CAD. However, a positive result on non-invasive
testing only moderately increased the diagnostic yield (41.0 vs.
35.0%) in their study.5 In contrast, our data demonstrate a substantial
incremental value of prior MPS in predicting obstructive CAD find-
ings by ICA over clinical risk factors and symptoms. The discrepancy
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Patient baseline characteristics by groups
Characteristic MPS
performed
n5 1773
No MPS
performed
n 5 5757
P-value
Male gender (%) 72.2 64.5 ,0.001
Age (years) NS
Median 67 67
Interquartile range 51–83 51–83
Cardiovascular risk factors
Body mass index (kg/m2) ,0.001
Median 27.1 26.7
Interquartile range 21.1–33.1 21.7–32.7
Smoking (%)
Former 34.5 18.4 ,0.005
Current 20.4 18.4 NS
Diabetes mellitus (%) 21.0 15.8 ,0.005
Hypertension (%) 67.7 52.5 ,0.001
Dyslipidaemia (%) 57.6 47.6 ,0.001
Positive family history (%) 32.7 22.8 ,0.001
Clinical symptoms (%)
Typical angina pectoris 51.0 41.9 ,0.001
Atypical chest pain 20.9 14.9 ,0.001
Dyspnoea 36.1 30.2 ,0.001
Exercise intolerance 24.8 15.2 ,0.001
Framingham Risk Score (%)
Low 27.1 35.8 ,0.001
Moderate 61.3 55.3 ,0.005
High 11.5 8.9 NS
CAD, coronary artery disease; MPS, myocardial perfusion single-photon-emission
computed tomography; NS, not significant.
Table 1 Patient baseline characteristics (n 5 7530)
Male gender (%) 66.3
Age (years)
Median 67
Interquartile range 51–83
Cardiovascular risk factors
Body mass index (kg/m2)
Median 26.8
Interquartile range 23.8–29.8
Smoking (%)
Former 22.2
Current 18.9
Diabetes mellitus (%) 17.1
Hypertension (%) 56.1
Dyslipidaemia (%) 50.0
Positive family history of (%) 25.2
Clinical symptoms (%)
Typical angina pectoris 44.1
Atypical chest pain 16.3
Dyspnoea 31.2
Exercise intolerance 17.5
Framingham Risk Score (%)
Low 33.7
Moderate 56.8
High 9.5
Figure 1 Comparison of rates of obstructive CAD as identified
by invasive coronary angiography between patients without MPS
imaging prior to elective invasive coronary angiography (black
boxes) and patients with a prior positive stress test (white boxes)
stratified by risk groups. While rates of obstructive CAD findings
increased with higher risk, the difference in rates for both groups
remained constant throughout all Framingham risk groups.
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with respect to thefindingsbyPatel et al.maybemainly due to the fact
that our analysis is based on cardiac imaging (MPS), whereas resting
electrocardiogram or resting echocardiography were not regarded
as tests suitable to predict ischaemia and consecutively the presence
of obstructive CAD.
In fact, in the present study, non-invasive MPS had an incremental
value in predicting obstructive CAD over clinical risk factors and
symptoms regardless of thepre-test probability as definedby the Fra-
mingham Risk Score. This further corroborates the clinical value of
cardiac imaging (MPS) in an every-day clinical population. While it
has been previously demonstrated that MPS plays an important
role as a gatekeeper by preventing unnecessary invasive proce-
dures,12,13 the present data extend this knowledge by demonstrating
that MPS also increases the diagnostic yield of invasive ICA, shifting
the focus more on its role as a gatekeeper for revascularization.14
This study also explores patterns of risk stratification prior to ICA.
Our study demonstrates a low rate of only 23.5% of patients having
undergone non-invasive MPS prior to the invasive procedure. Of
note, the majority particularly of patients at moderate risk for CAD
did not undergo MPS prior to ICA although documentation of
ischaemia is recommended by current guidelines particularly for
this population.15,16
Interestingly, in view of the above, the patient population in which
MPS was performed differed from the patients who did not undergo
MPS prior to ICA: in fact, with the exception of age, current smoking
status, and the ratio of patients at a high cardiovascular risk, all other
baseline characteristics differed significantly. Of note, the ratio of
patients at a low cardiovascular risk was higher in the group where
no MPS was performed while by contrast, the ratio of patients at
high risk did not differ statistically between the two groups. This
finding is surprising, as implementation of the current guidelines
would lead one to expect an opposite distribution.
Previous studies have demonstrated obstructive CAD findings at
catheterization of up to 60% but have applied more lenient inclusion
criteria.17 Thus, the low rate of obstructiveCAD in the present study
may to some extent be perceived as a reflection of stricter inclusion
criteria as patientswith a knownhistory ofCADor those undergoing
emergencyprocedures andpreoperative assessmentwereexcluded.
This is of importance with regard to the context and impact of our
Figure 2 Incremental value of information obtained before inva-
sive coronary angiography to predict obstructive coronary artery
disease. Model 1 included the Framingham Risk Score. Clinical
risk factors were added to Model 2, symptoms to Model 3, and
the results of non-invasive stress testing to Model 4.
Figure 3 Incremental value of information obtained before inva-
sive coronary angiography to predict obstructive coronary artery
disease in different risk populations. Clinical risk factors were
included in Model 1, symptoms were added to Model 2, and the
results of non-invasive stress testing to Model 3.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Independent predictors of coronary artery
disease (n5 7530)
Variable Odds ratio (95% CI) P-value
Male gender 3.07 (2.72–3.47) ,0.001
Typical angina pectoris 2.95 (2.63–3.30) ,0.001
Positive MPS 2.74 (2.36–3.19) ,0.001
Diabetes 1.80 (1.56–2.08) ,0.001
Smoking 1.38 (1.20–1.56) ,0.001
Positive family history 1.41 (1.24–1.60) ,0.001
Age (per year) 1.04 (1.03–1.04) ,0.001
CI, confidence interval; MPS, myocardial perfusion single photon emission
computed tomography.
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findings on clinical decisionmaking as our findings apply tomore than
two-thirds of all performed elective cardiac catheterizations of our
study population.
Although it has been shown that percutaneous coronary interven-
tion in addition to optimal medical treatment is not superior to
medical therapy alone in terms of prognosis and quality of life in
patients with stable CAD in general populations, 18,19 it remains an
important treatment option for obstructive CAD and its use has
increased several foldover the last decade.20Although the incidences
of periprocedural morbidity andmortality are low, diagnostic coron-
ary angiography may cause serious complications and, hence, the
benefits must justify the risks and appropriate patient selection is
crucial. This is particularly true in patients with a low-to-moderate
risk for obstructive CAD where the risk-to-benefit ratio is easily
shifted towards the unfavourable side of the balance.
With regard to the risk-to-benefit ratio, it is important to note that
aside from being non-invasive, nuclear cardiac imaging has recently
seen revolutionary milestone in technical innovation with the intro-
duction of cadmium-zinc-telluride detectors and sophisticated
iterative reconstruction algorithms, as this has led to a massive in-
crease in system sensitivity.21 This, in turn, allows either substantially
shortening the time needed for image acquisition22 or reduction of
radiotracer activity. The latter results in a radiation dose exposure
of around 5 mSv23 and even below.24 Such a reduction in radiation
dose exposure addresses valid concerns about radiation dose from
medical imaging and, importantly, places MPS at the same level with
invasive angiography.
It is against the abovementioned background that current recom-
mendations call for documentation of ischaemia by non-invasive
testing prior to ICA. However, while the present data document the
ability ofMPS to improve the diagnostic yield of coronary angiography,
it also reveals that such testing is not performed consistently and thus
highlights room for improvement in the clinical decision-making
process that leads to the diagnostic use of cardiac catheterization.
Limitations
Aside fromthe limitations that are inherent forany retrospective study,
we acknowledge a number of particular limitations of the present
work: the rate of non-invasive testing in our study is lower than
those reported in previous studies2,4 and is possibly underestimated
as we may have missed patients that underwent ICA only after unsuc-
cessful optimal medical therapy because of the 90-day time window
chosen in our study. Furthermore, we cannot comment on the
amount of non-invasive stress testing performed outside of our
clinic. While it is reasonable to assume that the amount is negligible
forMPS due to limited availability (our division being the only one per-
forming nuclear cardiac imaging within the average referral area of our
institution), the samemightnotbe true forother formsof stress testing
such as exercise stress testing or stress echocardiography. However,
against the background of the low rate of CAD findings during the in-
vasive procedure, we assume that this holds true only for aminority of
patients as a direct referral to ICAwouldonly take place in the eventof
a clearly pathological finding which would in turn expectedly again in-
crease the rate of CAD findings to some extent.
In thepresent study, ICAdidnot reveal at leastonecoronary lesion
with ≥50% luminal diameter narrowing in 25.6% of patients with an
abnormalMPS result. Several aspectsmay to someextent explain the
discrepant findings: for one, we cannot comment on the presence of
any angiographic borderline stenosis or sequential coronary lesions,
which may have led to ischaemia an identifiable culprit lesion. Con-
versely, we cannot comment on whether MPS borderline findings
(e.g. a SDS of 2) were overrepresented in these patients. More im-
portantly, however, the current work suffers from the methodol-
ogical limitation inherent to all studies comparing a functional vs. a
morphological test due to the well-known incongruence of function
and morphology.25
Finally, performanceof the FraminghamRisk Scoresmaybeunder-
estimated aswe substituted values for unknown lipid levels andblood
pressure.
Conclusions
In anevery-day clinical setting, non-invasiveMPShas the ability to sub-
stantially increase the diagnostic yield of elective ICA. Furthermore,
MPS provides incremental value over clinical risk factors and symp-
toms in predicting obstructiveCADfindings, thus emphasizing its im-
portance in the decision-making process that leads to the use of
cardiac catheterization.
Conflict of interest: none declared.
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Aortic forward flow in aortic atresia via ventriculo-coronary arterial
connections
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A full-termmale newbornweighing 2.7 kg was eval-
uated because of suspected cyanotic congenital
heart disease on the day of birth. The echocardio-
graphic study showed corrected transposition of
the great arteries, severe tricuspid stenosis, right
ventricular (RV) hypoplasia, aortic atresia, intact
ventricular septum, and ventriculo-coronary arter-
ial connections (VCACs) (Panel A, yellow arrow).
RV contraction created reverse flow in the right
coronary and left anterior descending coronary ar-
teries via theVCACs, resulting in forwardflow in the
ascending aorta (Panels B and C, see Supplementary
data online, Video S1). Computed tomographic angi-
ography on the third day of life also demonstrated
theVCACsbetween the hypoplastic RVand ascending aorta (Panels D andE). The patientwasmaintainedonprostaglandinE1, and bilateral
pulmonary arterial banding was performed on the 14th day of life. On the ninth postoperative day, echocardiography demonstrated a re-
strictive patent foramen ovale with accelerated flow velocity. Therefore, balloon atrial septostomy and right ventriculography were per-
formed. The examinationdemonstrated the presence of VCACs consistentwith the prior echocardiographic findings (Panels F andG). The
patient underwent the Norwood procedure with an LV-PA shunt on the 55th day of life. This is the first report of this anatomic variant.
Coronary insufficiency and critical ventricular dysfunction in the presence of VCACs is a well-described phenomenon in hypoplastic right
and left hearts. The present case had a definitively different blood flowpattern in the ascending aorta and coronary arteries comparedwith
these two representative anomalies with hypoplastic left or right ventricles.
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